A 60-year-old woman trying to discontinue hormone replacement therapy

JAMA. 2002 Apr 24;287(16):2130-7. doi: 10.1001/jama.287.16.2130.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alendronate / therapeutic use
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / prevention & control
  • Contraindications
  • Coronary Disease
  • Decision Making*
  • Estrogen Replacement Therapy*
  • Estrogens, Conjugated (USP) / therapeutic use
  • Female
  • Fibrocystic Breast Disease
  • Hot Flashes
  • Humans
  • Hysterectomy
  • Middle Aged
  • Osteoporosis, Postmenopausal
  • Ovariectomy
  • Raloxifene Hydrochloride / therapeutic use
  • Risk Assessment*
  • Risk Factors
  • Selective Estrogen Receptor Modulators / therapeutic use
  • Tamoxifen / therapeutic use
  • Venous Thrombosis

Substances

  • Estrogens, Conjugated (USP)
  • Selective Estrogen Receptor Modulators
  • Tamoxifen
  • Raloxifene Hydrochloride
  • Alendronate